Marseille-Kliniken AG

EANS-News: Marseille-Kliniken AG achieves strong earnings improvement

  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
Financial Figures/Balance Sheet/Preliminary half yearly results

Subtitle: - EBIT improved by more than 50 percent to EUR 5.0 million
- Revenues increased slightly to EUR 96.4 million
- Focusing on operational business clearly proves to be successful
- Earnings guidance of EUR 10.0 million for complete financial year confirmed

Hamburg, Germany (euro adhoc) - 20 January 2012 - Marseille-Kliniken AG could
improve its profitability in the first half of the 2011/2012 financial year (1
July through 31 December 2011) according to preliminary figures. EBIT rose by 56
percent to EUR 5.0 million (previous year: EUR 3.2 million). The occupancy rate
rose to 88.6 percent after an average of 87.1 percent in the past financial
year. Revenues increased slightly to EUR 96.4 million (previous year: EUR 95.2
million). "This further improvement of the profitability shows that our focusing
on the operational business could be successfully realized. We expect this
positive development to continue also in the whole financial year", says Michael
Thanheiser, chairman of Marseille-Kliniken AG.

In the previous financial year and in the first six months of the 2011/2012
financial year, Marseille-Kliniken AG reinforced its focus towards the core
competencies in inpatient and outpatient care for the elderly, strengthened its
quality leadership, and introduced a new, decentralised management structure.
Moreover a programme carried out to optimise costs also played a role in
supporting the company's economic recovery. Marseille-Kliniken AG operates a
total of 60 care facilities across Germany, with a sales capacity of 7,940 beds
on 31 December 2011.

Against the backdrop of the half yearly results, Marseille-Kliniken AG confirms
its forecast for the 2011/2012 financial year, which calls for a slight revenue
increase and Group EBIT of EUR 10.0 million, well above the previous year's
level. Most important aspect will remain the focusing on the core competency in
the nursing care business. Marseille-Kliniken AG will release the full results
for the first half of the 2011/2012 financial year on 8 February 2012. The
corresponding half yearly report will then be made available to the public on
the company's website at

Further inquiry note:
Christian Hillermann
Hillermann Consulting
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114

end of announcement                               euro adhoc 

company:     Marseille-Kliniken AG
             Alte Jakobstraße 79/80
             D-10179 Berlin
phone:       +49 (0)30 246 32-400
FAX:         +49 (0)30 246 32-401
sector:      Pharmaceuticals
ISIN:        DE0007783003
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Düsseldorf, Stuttgart, regulated dealing:
             Hamburg, regulated dealing/prime standard: Frankfurt 
language:   English

Weitere Meldungen: Marseille-Kliniken AG

Das könnte Sie auch interessieren: